United Therapeutics
UTHR
UTHR
511 hedge funds and large institutions have $12.3B invested in United Therapeutics in 2022 Q4 according to their latest regulatory filings, with 89 funds opening new positions, 168 increasing their positions, 177 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
11% more funds holding
Funds holding: 460 → 511 (+51)
5% less repeat investments, than reductions
Existing positions increased: 168 | Existing positions reduced: 177
1.55% less ownership
Funds ownership: 99.67% → 98.12% (-1.5%)
Holders
511
Holding in Top 10
23
Calls
$50.3M
Puts
$43.5M
Top Buyers
| 1 | +$306M | |
| 2 | +$46.3M | |
| 3 | +$46.2M | |
| 4 |
Morgan Stanley
New York
|
+$33.5M |
| 5 |
D.E. Shaw & Co
New York
|
+$31.9M |
Top Sellers
| 1 | -$223M | |
| 2 | -$98.6M | |
| 3 | -$73.1M | |
| 4 |
Renaissance Technologies
New York
|
-$51.9M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$46.6M |